These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 3473677

  • 1. In vivo development of cytosine arabinoside resistance in the BN acute myelocytic leukemia.
    Hagenbeek A, Martens AC, Colly LP.
    Semin Oncol; 1987 Jun; 14(2 Suppl 1):202-6. PubMed ID: 3473677
    [Abstract] [Full Text] [Related]

  • 2. Deoxycytidine kinase and deoxycytidine deaminase values correspond closely to clinical response to cytosine arabinoside remission induction therapy in patients with acute myelogenous leukemia.
    Colly LP, Peters WG, Richel D, Arentsen-Honders MW, Starrenburg CW, Willemze R.
    Semin Oncol; 1987 Jun; 14(2 Suppl 1):257-61. PubMed ID: 3035720
    [Abstract] [Full Text] [Related]

  • 3. Decreased resistance to gemcitabine (2',2'-difluorodeoxycitidine) of cytosine arabinoside-resistant myeloblastic murine and rat leukemia cell lines: role of altered activity and substrate specificity of deoxycytidine kinase.
    Bergman AM, Pinedo HM, Jongsma AP, Brouwer M, Ruiz van Haperen VW, Veerman G, Leyva A, Eriksson S, Peters GJ.
    Biochem Pharmacol; 1999 Feb 15; 57(4):397-406. PubMed ID: 9933028
    [Abstract] [Full Text] [Related]

  • 4. Effect of dexamethasone on the antileukemic effect of cytarabine: role of deoxycytidine kinase.
    Jaramillo AC, Bergman AM, Comijn EM, Jansen G, Kaspers GJL, Cloos J, Peters GJ.
    Nucleosides Nucleotides Nucleic Acids; 2020 Feb 15; 39(10-12):1346. PubMed ID: 32727269
    [Abstract] [Full Text] [Related]

  • 5. Lack of cross-resistance between cytosine arabinoside and a new halogenated nucleoside analogue, 2-bromo-2'-deoxyadenosine in human acute myeloid leukaemia cells.
    Pemble LB, Lihou MG, Blakley RL, Jamieson GP, Smith PJ.
    Cancer Chemother Pharmacol; 1987 Feb 15; 20(2):155-61. PubMed ID: 3499252
    [Abstract] [Full Text] [Related]

  • 6. In vivo studies on high-dose 1-beta-D-arabinofuranosylcytosine (HDara-C) and 1-beta-D-arabinofuranosyluracil (ara-U) with respect to pharmacokinetics, cell kinetics, and cytotoxicity in a rat myelocytic leukemia model (BNML).
    Colly LP, Willemze R, Honders W, vd Hoorn F, Edelbroek PM.
    Semin Oncol; 1985 Jun 15; 12(2 Suppl 3):49-54. PubMed ID: 3859932
    [Abstract] [Full Text] [Related]

  • 7. Studies on mechanisms of resistance to cytosine arabinoside: problems in the determination of related enzyme activities in leukemic cells.
    Coleman CN, Johns DG, Chabner BA.
    Ann N Y Acad Sci; 1975 Aug 08; 255():247-51. PubMed ID: 171992
    [No Abstract] [Full Text] [Related]

  • 8. A bioluminescent microbial biosensor for in vitro pretreatment assessment of cytarabine efficacy in leukemia.
    Alloush HM, Anderson E, Martin AD, Ruddock MW, Angell JE, Hill PJ, Mehta P, Smith MA, Smith JG, Salisbury VC.
    Clin Chem; 2010 Dec 08; 56(12):1862-70. PubMed ID: 20921267
    [Abstract] [Full Text] [Related]

  • 9. Structural analysis of the deoxycytidine kinase gene in patients with acute myeloid leukemia and resistance to cytosine arabinoside.
    Flasshove M, Strumberg D, Ayscue L, Mitchell BS, Tirier C, Heit W, Seeber S, Schütte J.
    Leukemia; 1994 May 08; 8(5):780-5. PubMed ID: 7514246
    [Abstract] [Full Text] [Related]

  • 10. Substrate-specific deoxycytidine kinase deficiency in 1-beta-D-arabinofuranosylcytosine-resistant leukemic cells.
    Richel DJ, Colly LP, Arkesteijn GJ, Arentsen-Honders MW, Kerster MG, ter Riet PM, Willemze R.
    Cancer Res; 1990 Oct 15; 50(20):6515-9. PubMed ID: 2208110
    [Abstract] [Full Text] [Related]

  • 11. In vitro biochemical tests to evaluate the response to therapy of acute leukemia with cytosine arabinoside or 5-AZA-2'-deoxycytidine.
    Onetto N, Momparler RL, Momparler LF, Gyger M.
    Semin Oncol; 1987 Jun 15; 14(2 Suppl 1):231-7. PubMed ID: 2438776
    [No Abstract] [Full Text] [Related]

  • 12. Concordant changes of pyrimidine metabolism in blasts of two cases of acute myeloid leukemia after repeated treatment with ara-C in vivo.
    Chiba P, Tihan T, Szekeres T, Salamon J, Kraupp M, Eher R, Köller U, Knapp W.
    Leukemia; 1990 Nov 15; 4(11):761-5. PubMed ID: 2232889
    [Abstract] [Full Text] [Related]

  • 13. Reduction of ara-C cytotoxicity in HL 60 cells by addition of deoxycytidine, cytidine or increased level of cytidine deaminase.
    Mejer J, Mortensen BT.
    Adv Exp Med Biol; 1989 Nov 15; 253B():335-9. PubMed ID: 2558539
    [No Abstract] [Full Text] [Related]

  • 14. Genetic factors influencing cytarabine therapy.
    Lamba JK.
    Pharmacogenomics; 2009 Oct 15; 10(10):1657-74. PubMed ID: 19842938
    [Abstract] [Full Text] [Related]

  • 15. Isolation and characterization of a deoxycytidine kinase-deficient human promyelocytic leukemic cell line highly resistant to 1-beta-D- arabinofuranosylcytosine.
    Bhalla K, Nayak R, Grant S.
    Cancer Res; 1984 Nov 15; 44(11):5029-37. PubMed ID: 6091869
    [Abstract] [Full Text] [Related]

  • 16. Association of polymorphisms of cytosine arabinoside-metabolizing enzyme gene with therapeutic efficacy for acute myeloid leukemia.
    Xu PP, Chen BA, Feng JF, Cheng L, Xia GH, Li YF, Qian J, Ding JH, Lu ZH, Wang XM, Xu K, Schultz M.
    Chin Med J (Engl); 2012 Jun 15; 125(12):2137-43. PubMed ID: 22884143
    [Abstract] [Full Text] [Related]

  • 17. Characterization of resistance to cytosine arabinoside (Ara-C) in NALM-6 human B leukemia cells.
    Kanno S, Hiura T, Ohtake T, Koiwai K, Suzuki H, Ujibe M, Ishikawa M.
    Clin Chim Acta; 2007 Feb 15; 377(1-2):144-9. PubMed ID: 17097625
    [Abstract] [Full Text] [Related]

  • 18. [Relationship between the expression of the genes encoding the key enzymes for cytarabine metabolism and the pharmacokinetics of cytarabine in the treatment of childhood acute leukemia with high-dose cytarabine].
    Xie XT, Jiang SY, Li BS, Yang LL.
    Zhonghua Er Ke Za Zhi; 2008 Apr 15; 46(4):276-80. PubMed ID: 19099730
    [Abstract] [Full Text] [Related]

  • 19. Intracellular cytarabine triphosphate production correlates to deoxycytidine kinase/cytosolic 5'-nucleotidase II expression ratio in primary acute myeloid leukemia cells.
    Yamauchi T, Negoro E, Kishi S, Takagi K, Yoshida A, Urasaki Y, Iwasaki H, Ueda T.
    Biochem Pharmacol; 2009 Jun 15; 77(12):1780-6. PubMed ID: 19428333
    [Abstract] [Full Text] [Related]

  • 20. Deoxycytidine kinase: properties of the enzyme from human leukemic granulocytes.
    Coleman CN, Stoller RG, Drake JC, Chabner BA.
    Blood; 1975 Nov 15; 46(5):791-803. PubMed ID: 51655
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.